Cytokinetics Inc. (CYTK) Financials
Key financial figures for Cytokinetics Inc. (Q3 2026).
Cytokinetics Inc. reported revenue of $47.6 million for Q3 FY2026, up 2356.5% from the same period a year earlier. The company posted a net loss of $190.1 million, or -$1.37 per share. Operating margin came to -351.34%, against -8613.38% a year earlier. Free cash flow for the period was -$124.7 million. Across the last 5 reported quarters, quarterly revenue has risen from $1.9 million in Q3 FY2025 to $47.6 million in Q3 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Cytokinetics Inc. are on the SentiSense financials page.
- Revenue
- $48M
- Net Income
- -$190M
- EPS
- $-1.37
- Total Assets
- $1.8B
- Operating Cash Flow
- -$124M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $48M | -$190M | -$1.37 | -351.34% | -$125M |
| Q2 FY2026 | $32M | -$199M | -$1.50 | -551.11% | -$164M |
| Q1 FY2026 | $19M | -$206M | -$1.67 | -948.69% | -$151M |
| Q4 FY2025 | $18M | -$183M | -$1.50 | -1004.6% | -$148M |
| Q3 FY2025 | $2M | -$306M | -$2.55 | -8613.38% | -$117M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $88M | -$785M | -$6.54 | -695.44% | -$535M |
| FY2024 | $18M | -$590M | -$5.26 | -2902.72% | -$400M |
| FY2023 | $8M | -$526M | -$5.45 | -6589.71% | -$416M |
Frequently asked questions
What was Cytokinetics Inc.'s revenue last quarter?
Cytokinetics Inc. reported revenue of $47.6 million for Q3 FY2026, up 2356.5% from the same period a year earlier.
Is Cytokinetics Inc. profitable?
Not in its most recent reported period. Cytokinetics Inc. reported a net loss of $190.1 million for Q3 FY2026, a net margin of -399.67% on revenue.
How has Cytokinetics Inc.'s margin trended?
Operating margin was -351.34% in Q3 FY2026, compared with -8613.38% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Cytokinetics Inc. generate?
Cytokinetics Inc. generated free cash flow of -$124.7 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Cytokinetics Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.